Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a caucasian population with atherosclerosis obliterans

Journal of Internal Medicine

Volumn 263, Issue 4, 2008, Pages 395-403

  Vriese, A S De ^a,b   Billiet, J ^c   Droogenbroeck, J Van ^b   Ghekiere, J ^b   Letter, J A De ^b  

^a Renal Unit   (Belgium)

^b NONE   (Belgium)

^c Laboratory of Hematology   (Belgium)

Author keywords

Bone marrow transplantation; Limp ischemia; Stem cells

Indexed keywords

AGED; ANALYTIC METHOD; ANKLE BRACHIAL INDEX; ARTICLE; ASIAN; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; BUERGER DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIMB ISCHEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; SMOKING; TRANSCUTANEOUS OXYGEN MONITORING; UREMIA;

AGE FACTORS; AGED; ANGIOGENESIS INDUCING AGENTS; ANGIOGRAPHY, DIGITAL SUBTRACTION; ARTERIOSCLEROSIS OBLITERANS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; ISCHEMIA; LIMB SALVAGE; MALE; PROGNOSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 40349088825     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01899.x     Document Type: Article

References (22)

1. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004 109 : 2692 7.
2. Collinson DJ, Donnelly R. Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? Eur J Vasc Endovasc Surg 2004 28 : 9 23.
3. Emmerich J. Current state and perspective on medical treatment of critical leg ischemia: gene and cell therapy. Int J Low Extrem Wounds 2005 4 : 234 41.
4. Dzau VJ, Gnecchi M, Pachori AS, Morello F, Melo LG. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 2005 46 : 7 18.
5. Hoetzer GL, Van Guilder GP, Irmiger H, Keith RS, Stauffer BL, Desouza CA. Aging, exercise and endothelial progenitor cell clonogenic and migratory capacity in men. J Appl Physiol 2007 102 : 847 52.
6. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 106 : 2781 6.
7. Chen JZ, Zhang FR, Tao QM, Wnag XX, Zhu JH. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolemia. Clin Sci 2004 107 : 273 80.
8. De Groot K, Bahlmann FH, Sowa J, Koenig J, Menne J, Haller H, et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int 2004 66 : 641 6.
9. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 2003 348 : 593 600.
10. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis - results from a large population-based study (Abstract). Atherosclerosis 2007 193 : S5.
11. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002 360 : 427 35.
12. Yamamoto K, Kondo T, Suzuki S, Izawa H, Kobayashi M, Emi N, et al. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs. Therapeutic effect by stem cell transplantation. Arterioscler Thromb Vasc Biol 2004 24 : e192 6.
13. Saigawa T, Kato K, Ozawa T, Toba K, Makiyama Y, Minagawa S, et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004 68 : 1189 93.
14. Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, Nakagawa K, et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004 109 : 1215 8.
15. Koshikawa M, Shimodaira S, Yoshioka T, Kasai H, Watanabe N, Wada Y, et al. Therapeutic angiogenesis by bone marrow implantation for critical hand ischemia in patients with peripheral arterial disease: a pilot study. Curr Med Res Opin 2006 22 : 793 8.
16. Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thrombangiitis obliterans. J Vasc Surg 2006 44 : 732 9.
17. Inaba S, Egashira K, Komori K. Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? (Letter). Lancet 2002 360 : 2083.
18. Huang PP, Li SZ, Han MZ, Xiao ZJ, Ynag RC, Qiu LG, et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost 2004 91 : 606 9.
19. Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care 2005 28 : 2155 60.
20. Ishida A, Ohya Y, Sakuda H, Ohshiro K, Higashiuesato Y, Nakaema M, et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J 2005 69 : 1260 5.
21. Kim SW, Han H, Chae GT, Lee SH, Bo S, Yoon JH, et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 2006 24 : 1620 6.
22. De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH. Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol 2003 14 : 2109 18.